Nigeria's High Sickle Cell Burden
Analysis based on 7 articles · First reported Apr 21, 2026 · Last updated Apr 22, 2026
The study highlights a significant public health challenge in Nigeria, which could lead to increased focus and investment in healthcare infrastructure and pharmaceutical solutions for sickle cell disease. This could create opportunities for companies involved in diagnostics, treatments, and public health initiatives in the region.
A new international study published in The Lancet reveals that Nigeria has the highest global burden of sickle cell disease (SCD), with over 1.5 million children under 15 affected. The study, led by Professor Davies Adeloye of Teesside University, analyzed data from 22 African countries, finding nearly nine million children with SCD across sub-Saharan Africa. The findings underscore the severity of the crisis in Nigeria, which far exceeds other high-burden nations like Democratic Republic of the Congo and Ethiopia. Experts emphasize that many complications and deaths from SCD are preventable with early diagnosis and low-cost interventions, but access to these services remains limited in Nigeria. The researchers call for urgent action, including expanding newborn screening, improving access to medicines, and integrating SCD care into routine maternal and child health services, suggesting that Nigeria has a unique opportunity to lead Africa in managing the condition.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard